The findings from this study suggest that given appropriate doses, IL-10 has the potential to modulate Mφ phenotypes in vitro and to ameliorate cardiac functional deterioration, reduce myocardial inflammation and fibrosis, and promote revascularization in the context of MI in vivo (Figure 8). Here, IL10 is linked to myocardial infarction.